;
Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Intellect Neurosciences management update

    Intellect Neurosciences Inc. (OTCBB:ILNS), New York, N.Y. Business: Neurology Transitioned: Elliot Maza, a director, to CEO and chairman, while remaining CFO

    Published on 8/11/2014
  • Orgenesis management update

    Orgenesis Inc. (OTCQB:ORGS), White Plains, N.Y. Business: Endocrine/Metabolic Hired: Scott Carmer as CEO of Orgenesis North American subsidiary

    Published on 8/11/2014
  • PTC management update

    PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Pulmonary, Cancer, Infectious Resigning: Claudia Hirawat as president

    Published on 8/11/2014
  • Rapid Biosensors Systems board of directors update

    Rapid Biosensors Systems Ltd., Cambridge, U.K. Business: Diagnostic Appointed: John Reynolds as executive chairman

    Published on 8/11/2014
  • RestorGenex management update

    RestorGenex Corp. (OTCQB:RESX), Los Angeles, Calif. Business: Cancer, Dermatology, Ophthalmic Hired: Mark Weinberg as SVP of clinical development, formerly VP of global clinical science at the Astellas Pharma Global …

    Published on 8/11/2014
  • Sorrento management update

    Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Business: Cancer, Antibodies Deceased: CBO and EVP Amar Singh

    Published on 8/11/2014
  • Synta management update

    Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Hired: Anne Whitaker as president, CEO and a director, effective Sept. 2, formerly president of North America pharmaceuticals at …

    Published on 8/11/2014
  • TesoRx Pharma management update

    TesoRx Pharma LLC, Menlo Park, Calif. Business: Endocrine/Metabolic Hired: Michael Oefelein as CMO, formerly CMO of Digirad Corp.

    Published on 8/11/2014
  • Theravance management update

    Theravance Inc. (NASDAQ:THRX), South San Francisco, Calif. Business: Infectious, Gastrointestinal, Pulmonary Transitioning: Michael Aguiar to president and CEO, effective Aug. 15, and a director, effective immediately, …

    Published on 8/11/2014
  • Zogenix management update

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Departed: Scott Shively as EVP and chief commercial officer to become SVP and chief commercial officer of Depomed Inc.; CEO Roger Hawley will assume the …

    Published on 8/11/2014
  • Aegerion management update

    Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Cambridge, Mass. Business: Cardiovascular, Endocrine/Metabolic Transitoned: Carolina Alarco to president, international from VP and general manager, international; and Craig …

    Published on 8/4/2014
  • Arsia Therapeutics management update

    Arsia Therapeutics Inc., Waltham, Mass. Business: Cancer, Antibodies Hired: Amy Schulman as CEO, formerly general counsel and EVP at Pfizer Inc.

    Published on 8/4/2014
  • Biocon management update

    Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Business: Biosimilars, Biomanufacturing, Supply/Service Transitioned: Siddharth Mittal, president of finance, to CFO; he succeeds Murali Krishnan, who retired

    Published on 8/4/2014
  • Celldex management update

    Celldex Therapeutics Inc. (NASDAQ:CLDX), Needham, Mass. Business: Cancer, Infectious, Renal Promoted: Elizabeth Crowly to SVP of product development from VP of product development; Thomas Davis to EVP from SVP, while …

    Published on 8/4/2014
  • Cold Genesys board of directors update

    Cold Genesys Inc., Irvine, Calif. Business: Cancer Appointed: David Nikodem, managing director and head of biopharma investments at Ally Bridge Group

    Published on 8/4/2014
  • Dendreon management update

    Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. Business: Cancer Hired: Thomas Amick as president, CEO and a director, formerly CEO and chairman of Discovery Laboratories Inc.; he succeeds John Johnson, who is departing

    Published on 8/4/2014
  • Egalet management update

    Egalet Corp. (NASDAQ:EGLT), Wayne, Pa. Business: Neurology, Cardiovascular, Drug delivery Hired: Jeffrey Dayno as CMO, formerly VP of global medical affairs at ViroPharma Inc., which Shire plc acquired; he succeeds …

    Published on 8/4/2014
  • Epic Sciences board of directors update

    Epic Sciences Inc., La Jolla, Calif. Business: Diagnostic Appointed: Gregory Lucier as chairman, formerly chairman and CEO of Life Technologies Corp., which Thermo Fisher Scientific Inc. acquired

    Published on 8/4/2014
  • Human Longevity management update

    Human Longevity Inc., San Diego, Calif. Business: Genomics, Cancer, Endocrine/Metabolic Hired: Franz Och as chief data scientist, formerly distinguished research scientist and head of Google Translate at Google Inc.

    Published on 8/4/2014
  • Inform Genomics management update

    Inform Genomics Inc., Boston, Mass. Business: Diagnostic Hired: Carl de Moor as chief technology officer, formerly senior principal epidemiology and lead at the Epidemiology Center of Excellence at IMS Health Holdings …

    Published on 8/4/2014
  • Intra-Cellular management update

    Intra-Cellular Therapies Inc. (NASDAQ:ITCI), New York, N.Y. Business: Neurology Hired: Michael Halstead as SVP and general counsel, formerly SVP of corporate development at Warner Chilcott plc, which combined with …

    Published on 8/4/2014
  • Rafarma Pharmaceuticals management update

    Rafarma Pharmaceuticals Inc. (Pink:RAFA), Draper, Utah Business: Infectious, Cancer, Generics Hired: Bruno Horn as president and a director

    Published on 8/4/2014
  • Rigontec management update

    Rigontec GmbH, Siegburg, Germany Business: Cancer Hired: Annegret de Baey-Diepolder as acting CEO, formerly CEO of ImmunOligo GmbH

    Published on 8/4/2014
  • Sarepta Therapeutics board of directors update

    Sarepta Therapeutics Inc. (NASDAQ:SRPT), Cambridge, Mass. Business: Infectious, Musculoskeletal Appointed: John Hodgman, a director, as interim chairman; he succeeds William Goolsbee, who resigned as chairman, while …

    Published on 8/4/2014
  • Serenus management update

    Serenus Biotherapeutics Inc., San Francisco, Calif. Business: Infectious Hired: Moosa Areff as COO, formerly CEO of the Sonke Pharmaceuticals subsidiary of Ranbaxy Laboratories Ltd.; and Andrew de Pao as CBO, formerly …

    Published on 8/4/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993